The DOI matches its Crossref record; 34 of the 34 references it cites were found in a registry or an index.
Structural Requirements for Binding of Anandamide-Type Compounds to the Brain Cannabinoid Receptor
Open accessAbstract
In order to establish the structural requirements for binding to the brain cannabinoid receptor (CB1), we have synthesized numerous fatty acid amides, ethanolamides, and some related simple derivatives and have determined their Ki values. A few alpha-methyl- or alpha, alpha-dimethylarachidonoylalkylamides were also examined. In the 20:4, n-6 series, the unsubstituted amide is inactive; N-monoalkylation, at least up to a branched pentyl group, leads to significant binding. N,N-Dialkylation, with or without hydroxylation on one of the alkyl groups, leads to elimination of activity. Hydroxylation of the N-monoalkyl group at the omega carbon atom retains activity. In the 20x, n-6 series, x has to be either 3 or 4; the presence of only two double bonds leads to inactivation. In the n-3 series, the limited data reported suggest that the derived ethanolamides are either inactive or less active than comparable compounds in the n-6 series. Alkylation or dialkylation of the alpha carbon adjacent to the carbonyl group retains the level of binding in the case of anandamide (compounds 48, 49); however, alpha-monomethylation or alpha,alpha-dimethylation of N-propyl derivatives (50-53) potentiates binding and leads to the most active compounds seen in the present work (Ki values of 6.9 +/- 0.7 to 8.4 +/- 1.1 nM). We have confirmed that the presence of a chiral center on the N-alkyl substituent may lead to enantiomers which differ in their levels of binding (compounds 54, 57 and 55, 56).
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Isolation and Structure of a Brain Constituent That Binds to the Cannabinoid Receptor
Devane, W. A., Hanuš, L., Breuer, A., Pertwee, R. G., Stevenson, L. A., Griffin, G., Gibson, D., Mandelbaum, A., Etinger, A., & Mechoulam, R. (1992) · Science · doi:10.1126/science.1470919 · Cited by 5,633
Self-citationIsolation, Structure, and Partial Synthesis of an Active Constituent of Hashish
Gaoni, Y., & Mechoulam, R. (1964) · Journal of the American Chemical Society · doi:10.1021/ja01062a046 · Cited by 2,393
Self-citationFormation and inactivation of endogenous cannabinoid anandamide in central neurons
Di Marzo, V., Fontana, A., Cadas, H., Schinelli, S., Cimino, G., Schwartz, J.-C., & Piomelli, D. (1994) · Nature · doi:10.1038/372686a0 · Cited by 1,587
Recognition of a lipid antigen by CD1-restricted αβ+ T cells
Beckman, E. M., Porcelli, S. A., Morita, C. T., Behar, S. M., Furlong, S. T., & Brenner, M. B. (1994) · Nature · doi:10.1038/372691a0 · Cited by 978
Enzymatic synthesis and degradation of anandamide, a cannabinoid receptor agonist
Deutsch, D. G., & Chin, S. A. (1993) · Biochemical Pharmacology · doi:10.1016/0006-2952(93)90486-g · Cited by 702
Facci, L., Dal Toso, R., Romanello, S., Buriani, A., Skaper, S. D., & Leon, A. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.8.3376 · Cited by 632
Chemical characterization of a family of brain lipids that induce sleep
Cravatt, B. F., Prospero-Garcia, O., Siuzdak, G., Gilula, N. B., Henriksen, S. J., Boger, D. L., & Lerner, R. A. (1995) · Science · doi:10.1126/science.7770779 · Cited by 620
Felder, C. C., Briley, E. M., Axelrod, J., Simpson, J. T., Mackie, K., & Devane, W. A. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.16.7656 · Cited by 475
N-Acylated glycerophospholipids and their derivatives
Schmid, H. H. O., Schmid, P. C., & Natarajan, V. (1990) · Progress in Lipid Research · doi:10.1016/0163-7827(90)90004-5 · Cited by 451
Pharmacological activity of the cannabinoid receptor agonist, anandamide, a brain constituent
Fride, E., & Mechoulam, R. (1993) · European Journal of Pharmacology · doi:10.1016/0014-2999(93)90468-w · Cited by 451
Self-citationThe pharmacological activity of anandamide, a putative endogenous cannabinoid, in mice.
Smith, P. B., Compton, D. R., Welch, S. P., Razdan, R. K., Mechoulam, R., & Martin, B. R. (1994) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)22356-4 · Cited by 393
Self-citation(R)-Methanandamide: A Chiral Novel Anandamide Possessing Higher Potency and Metabolic Stability
Abadji, V., Lin, S., Taha, G., Griffin, G., Stevenson, L. A., Pertwee, R. G., & Makriyannis, A. (1994) · Journal of Medicinal Chemistry · doi:10.1021/jm00038a020 · Cited by 346
Two new unsaturated fatty acid ethanolamides in brain that bind to the cannabinoid receptor
Hanus, L., Gopher, A., Almog, S., & Mechoulam, R. (1993) · Journal of Medicinal Chemistry · doi:10.1021/jm00072a026 · Cited by 334
Self-citationVogel, Z., Barg, J., Levy, R., Saya, D., Heldman, E., & Mechoulam, R. (1993) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1993.tb03576.x · Cited by 300
Self-citationSchmid, P. C., Krebsbach, R. J., Perry, S. R., Dettmer, T. M., Maasson, J. L., & Schmid, H. H. O. (1995) · FEBS Letters · doi:10.1016/0014-5793(95)01194-j · Cited by 235
Sugiura, T., Kondo, S., Sukagawa, A., Tonegawa, T., Nakane, S., Yamashita, A., Ishima, Y., & Waku, K. (1996) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1996.0053h.x · Cited by 211
A novel probe for the cannabinoid receptor
Devane, W. A., Breuer, A., Sheskin, T., Jaerbe, T. U. C., Eisen, M. S., & Mechoulam, R. (1992) · Journal of Medicinal Chemistry · doi:10.1021/jm00089a018 · Cited by 205
Self-citationNovel antagonist implicates the CB1 cannabinoid receptor in the hypotensive action of anandamide
Varga, K., Lake, K., Martin, B. R., & Kunos, G. (1995) · European Journal of Pharmacology · doi:10.1016/0014-2999(95)00181-j · Cited by 201
Sugiura, T., Kondo, S., Sukagawa, A., Tonegawa, T., Nakane, S., Yamashita, A., & Waku, K. (1996) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1996.0020 · Cited by 197
Weidenfeld, J., Feldman, S., & Mechoulam, R. (1994) · Neuroendocrinology · doi:10.1159/000126646 · Cited by 177
Self-citationEffects of anandamide on cannabinoid receptors in rat brain membranes
Childers, S. R., Sexton, T., & Roy, M. B. (1994) · Biochemical Pharmacology · doi:10.1016/0006-2952(94)90134-1 · Cited by 176
Munro, S. (1996) · Trends in Pharmacological Sciences · doi:10.1016/0165-6147(96)81598-7 · Cited by 154
Bayewitch, M. L., Rhee, M. H., Avidor‐Reiss, T., Breuer, A., Mechoulam, R., & Vogel, Z. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.17.9902 · Cited by 149
Self-citationYang, G., & Masland, R. H. (1992) · Science · doi:10.1126/science.1470920 · Cited by 146
Evaluation of cannabinoid receptor binding and in vivo activities for anandamide analogs.
Adams, I. B., Ryan, W. J., Singer, M. M., Thomas, B. F., Compton, D. M., Razdan, R. K., & Martin, B. R. (1995) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)09592-8 · Cited by 136
Search for endogenous ligands of the cannabinoid receptor
Mechoulam, R., Hanuš, L., & Martin, B. R. (1994) · Biochemical Pharmacology · doi:10.1016/0006-2952(94)90197-x · Cited by 127
Self-citationKempe, K. C., Hsu, F., Bohrer, A., & TURK, J. W. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.29.17287 · Cited by 114
Cannabinoid receptor binding and agonist activity of amides and esters of arachidonic acid.
PINTO, J. C., Potié, F., Rice, K. C., Boring, D. L., Johnson, M. R., Evans, D. M., Wilken, G. H., Cantrell, C. H., & Howlett, A. C. (1994) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)09729-9 · Cited by 109
Fontana, A., Marzo, V. D., Cadas, H., et al. (1995) · Prostaglandins Leukotrienes and Essential Fatty Acids · doi:10.1016/0952-3278(95)90130-2 · Cited by 76
Rationally designed, potent competitive inhibitors of leukotriene biosynthesis
Corey, E. J., Cashman, J. R., Kantner, S. S., et al. (1984) · Journal of the American Chemical Society · doi:10.1021/ja00317a064 · Cited by 71
Pharmacological and behavioral evaluation of alkylated anandamide analogs
Adams, I. B., Ryan, W. J., Singer, M., Razdan, R. K., Compton, D. M., & Martin, B. R. (1995) · Life Sciences · doi:10.1016/0024-3205(95)00187-b · Cited by 70
The endogenous cannabinoid receptor agonist anandamide impairs memory in rats
Mallet, P. E., & Beninger, R. J. (1996) · Behavioural Pharmacology · doi:10.1097/00008877-199605000-00008 · Cited by 67
Barg, J., Fride, E., Hanus, L. O., Levy, R., Matus-Leibovitch, N., Heldman, E., Bayewitch, M. L., Mechoulam, R., & Vogel, Z. (1995) · European Journal of Pharmacology · doi:10.1016/0014-2999(95)00487-4 · Cited by 67
Self-citationEndogenous and Synthetic Cannabinoids: Recent Advances
Shohami, E., Weidenfeld, J., Ovadia, H., Vogel, Z., Harnuš, L., Fride, E., Breuer, A., Ben‐Shabat, S., Sheskin, T., & Mechoulam, R. (1996) · CNS Drug Reviews · doi:10.1111/j.1527-3458.1996.tb00310.x · Cited by 13
Self-citation
Cited by
International Union of Pharmacology. XXVII. Classification of Cannabinoid Receptors
Howlett, A. C., Barth, F., Bonner, T. I., Cabral, G., Casellas, P., Devane, W. A., Felder, C. C., Herkenham, M., Mackie, K., Martin, B. R., et al. (2002) · Pharmacological Reviews · doi:10.1124/pr.54.2.161 · Cited by 2,819
Self-citationPharmacological Actions of Cannabinoids
Pertwee, R. G. (2005) · Handbook of Experimental Pharmacology · doi:10.1007/3-540-26573-2_1 · Cited by 597
Cannabinoid receptors and their ligands
Pertwee, R. G., & Ross, R. A. (2002) · Prostaglandins, Leukotrienes and Essential Fatty Acids (PLEFA) · doi:10.1054/plef.2001.0341 · Cited by 561
Howlett, A. C. (2002) · Prostaglandins & Other Lipid Mediators · doi:10.1016/s0090-6980(02)00060-6 · Cited by 535
A biosynthetic pathway for anandamide
Liu, J., Wang, L., Harvey-White, J., Osei-Hyiaman, D., Razdan, R., Gong, Q., Chan, A. C., Zhou, Z., Huang, B. X., Kim, H.-Y., et al. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0601832103 · Cited by 470
Metadata
- Authors
- Sheskin, T., Hanuš, L., Slager, J., Vogel, Z., & Mechoulam, R.
- Venue
- Journal of Medicinal Chemistry
- Publisher
- American Chemical Society (ACS)
- Published
- 1997-02-01
- Volume
- 40
- Issue
- 5
- Pages
- 659-667
- ISSN
- 0022-2623 (ISSN-L)
- 1520-4804
- OpenAlex
- W1975161769
- Cited by
- 275
- References
- 34
- FWCI
- 7.96
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.